SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950142-21-001168
Filing Date
2021-04-01
Accepted
2021-04-01 17:22:23
Documents
2
Group Members
CHRIS SHUMWAYCRESTOVO INVESTOR LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D eh210141468_13d-finch.htm SC 13D 78277
2 EXHIBIT 1 eh210141468_ex9901.htm EX-99.1 5606
  Complete submission text file 0000950142-21-001168.txt   85399
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Subject) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92403 | Film No.: 21799376
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 28 HAVEMEYER PLACE GREENWICH CT 06830
Business Address 28 HAVEMEYER PLACE GREENWICH CT 06830 203-485-8550
Crestovo Investor LLC (Filed by) CIK: 0001849829 (see all company filings)

IRS No.: 474476622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D